M&A Project

1.Global Company E
Extracorporeal Blood Purification
Whole Company
5~10B Euro
Controlled by Capital Investment Fund

2.Global Corporation R
Extracorporeal Blood Purification
Global Business Unit
50~100M Euro
Divestment of non-core business

3.European Private Company D
Medical Device
Whole company
30~60M Euro
Owner retiring

4.Global Corporation A
(Wholly-owned manufacturing subsidiary)
Medical Device
Close of wholly-owned manufacturing site
30M Euro
Decline in revenue; Non-profitable